Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
2
Mins
31 Jul 2018
Physician Global Assessments for Disease Activity in Rheumatoid Arthritis Are All Over the Map!
There have been many studies about patient global assessments of disease activity in rheumatoid arthritis (RA) and how these differ from physician global…
8
Mins
31 Jul 2018
Editor's Pick: JAK Inhibitors in the Treatment Algorithm of Rheumatoid Arthritis: A Review
Biological disease-modifying antirheumatic drugs have defined a new era in rheumatoid arthritis (RA) management but share the limitation of antagonising…
4
Mins
31 Jul 2018
Congress Feature from EULAR 2018
Building on last year’s launch, the EULAR ‘Don’t Delay, Connect Today’ campaign was a highlight of this year’s EULAR Congress. As part of EMJ’s…
10
Mins
31 Jul 2018
Switching to Biosimilars in Inflammatory Rheumatic Conditions: Current Knowledge
Biosimilars are more affordable versions of previously approved biopharmaceuticals that are designed to reduce healthcare expenditure and increase…
1
Mins
31 Jul 2018
Linking Systemic Angiogenic Markers to Synovial Vascularisation in Rheumatoid Arthritis
The synovium is the primary site of the rheumatoid arthritis (RA)-related inflammatory process. One of the most noticeable signs of synovitis is the…
9
Mins
31 Jul 2018
Primary Sjögren’s Syndrome in the Elderly: Does Age of Onset Make a Difference?
Primary Sjögren’s syndrome (pSS) is a relatively common disease and one of the most common rheumatic diseases
2
Mins
31 Jul 2018
Development and Implementation of an Educational Video That Instructs Patients with Rheumatoid Arthritis for Self-Assessment of Disease Activity: Methodology of the AUTO-DAS in Middle Eastern Arab Countries Study
The treat-to-target concept has revolutionised rheumatoid arthritis (RA) management and prognosis. Using a specific treatment target, such as Disease…
1
Mins
31 Jul 2018
Adiponectin Level, Insulin Resistance, and Endothelial Dysfunction in Hypertensive Females with Rheumatoid Arthritis
Rheumatoid arthritis (RA) is associated with accelerated atherosclerosis and high cardiovascular mortality. Cardiovascular risk assessment in RA patients…
10
Mins
31 Jul 2018
Cytokines and Inflammatory Mediators in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a breakdown in immune tolerance
2
Mins
31 Jul 2018
Changes in Bone Mineral Density Over 10 Years in Patients with Early Rheumatoid Arthritis
Patients with rheumatoid arthritis (RA) have been shown to have an increased risk of osteoporosis and fractures. Most studies on RA and osteoporosis…
←
1
2
3
…
785
786
787
788
789
790
791
…
1,113
1,114
1,115
→
We’ve noticed you’re accessing
from
North/South America.
View
View